Pham Quang X

Chairman, CEO and Interim CFO, Director, 10% OwnerCadrenal Therapeutics, Inc. (CVKD) · full profile →Form 4 · filed Jun 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$34K
Net Open-Market Flow
-$34K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 26, 2026Sell(S)9K$3.05$28K106K
Jun 25, 2026Sell(S)2K$3.00$6K115K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-072789) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about CVKD insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001213900-26-072789"
Ask your agent
Use Arkolith to summarize insider buying and selling at Cadrenal Therapeutics, Inc.
over the last 90 days and cite the filings.